Toxic relationships don’t just happen in romance, families, or friendships—they can happen in your body too. Type 2 diabetes (T2D) and obesity form one such harmful partnership, creating a cycle of worsened blood sugar and weight gain.

Fortunately, Rybelsus, the revolutionary oral semaglutide by Novo Nordisk, empowers patients to fight T2D and obesity—a pairing that coexists in over 90% of cases—this game-changing treatment delivers effective blood sugar control and sustainable weight loss.

We partnered with Novo Nordisk to create a video campaign featuring India’s top endocrinologists to share how they could literally “lower their weight of diabetes”. By highlighting the transformative impact of Rybelsus.

Featured, Dr. Jyothydev, India’s leading endocrinologist, discusses the transformative impact of Rybelsus, with this interesting analogy.

Leave a Reply